Can a blood test predict organ failure in septic shock?
Part of Infections clinical trials.
This trial is studying a blood marker called GDF-15 to see if it can predict which patients with septic shock might develop multiple organ failure. If you have septic shock and do not have certain other serious health conditions, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with septic shock
- You do not have end-stage kidney failure
- You do not have chronic liver disease
- You do not have advanced heart failure (NYHA stage 3 or 4)
- You are not pregnant, do not have active cancer, and do not have a chronic immune or inflammatory disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
This study tests two new blood tests to see if they can help doctors find sepsis earlier in the emergency department. Sepsis is a serious condition where the body overreacts to an infection, and finding it quickly could lead to faster treatment and better outcomes.
This study looks at two simple blood tests (one for sugar and fat levels, one for inflammation) to see if they can help doctors spot heart problems early in people with septic shock. It might help improve care for future patients.
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
This study uses a special ultrasound (Doppler) to check blood flow to your organs during septic shock. It helps doctors see if your body is getting enough blood and oxygen, which may guide better treatment.
This trial checks if a blood test measuring renin (a kidney hormone) can help predict how severe septic shock will be and how well patients recover. It looks for early clues in ICU patients with sepsis.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.